Authors


Abigail Johnson

Latest:

Study Highlights Pharmacy Student Perspective on Mental Health, Future Practice

Pharmacy programs are implementing new practices into their curriculum and research is being focused on mental health care.


Gabriela G. Abrego, MPH

Latest:

Applying an Error Prevention Process to a COVID-19 Vaccination Clinic

An overview for community pharmacies of a process to minimize vaccine errors using a COVID-19 vaccine point of distribution as an example.


Pranav Garimella, MBBS, MPH

Latest:

Insight: Pharmacists Play Key Role in Educating Patients With CKD on Semaglutide Use, Management

According to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.


Natalija M. Farrell, PharmaD, BCPS, DABAT, FAACT

Latest:

Vaccinations in the Emergency Department: Current and Emerging Practices to Boost Public Health

Piloting new emergency department-based vaccination campaigns and fine-tuning existing programs may reduce morbidity and mortality associated with vaccine-preventable diseases.




Ila M. Saunders, PharmD, BCOP, DipACLM, FHOPA

Latest:

Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML

CPX-351 shows promise for younger adults with therapy-related AML, offering improved survival post-transplant despite lower initial remission rates.


Jacob Curcio, PharmD

Latest:

A Primer for Medical Specialty Drug Utilization Management Strategies

Case management programs or pharmacist-delivered high-touch care are critical components in medical specialty drug management.


Rachel A. Galbo, PharmD, BCACP, CDCES

Latest:

A Pharmacist’s Guide to Continuous Glucose Monitoring

This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.


Lana Shalumova, PharmD, CSP

Latest:

The Role of Specialty Pharmacists in Managing Chronic Kidney Disease

Specialty pharmacists enhance CKD management through personalized care, medication adherence strategies, and collaboration with health care providers.


Amir Ali, PharmD, BCOP

Latest:

Zanidatamab Is a Breakthrough in HER2- Positive Biliary Tract Cancer Treatment

The FDA approves zanidatamab for HER2-positive biliary cancer, improving treatment options.


Karen Kobelski, MBA

Latest:

Compounding Confidence: Navigating Challenges With Innovative Technology in Pharmacy

Hospital compounding is gaining renewed attention amid drug shortages, regulatory changes, and labor challenges, prompting pharmacies to leverage advanced technology for safer, more efficient, and compliant medication preparation.


Sarah O'Neill, PharmD

Latest:

Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple Myeloma

Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.


Amy C. Nieto, BS, PharmD Candidate

Latest:

A Pharmacist’s Guide to New IDSA Guidelines for Complicated UTIs

IDSA updated cUTI guidelines for men and women emphasize antibiotic selection, transition to oral therapy, and optimal treatment duration.


Dawn DiPasquale, CPhT, CTDP

Latest:

Education, Training, Collaboration Key Areas of Focus at ASHP

Shields Health Solutions poster presentations highlight a comprehensive approach to specialty patient care and successful results from an expanded offering of instructional programs.


Sarah E Leist, PharmD Candidate

Latest:

Purchasing Discounted Medications Online Can Pose Dangers for Patients

With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.


Ariana Paras, PharmD Candidate

Latest:

Bridging the Gap: How Pharmacists Can Expand and Transform Mental Health Services

This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.



Sarah A. Alwardt, PhD

Latest:

Lung Cancer Study Brings Pharmacists to the Forefront of Patient Care

Pharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.


Melissa George, PharmD, BCIDP

Latest:

Expanded Use of Long-Acting Injectables for HIV and HIV Prevention

As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.


Ryan Himes, PharmD

Latest:

Pharmacists Can Intervene in Commonly Overlooked Medication Errors

Pharmacists enhance patient safety by addressing common medication errors, ensuring proper drug use, and improving therapeutic outcomes in clinical practice.


Lauren Caldas, PharmD, BCACP

Latest:

Lessons Learned by a Student Pharmacist on Instagram

There are key benefits and risks for student pharmacists to consider when approaching an Instagram account for professional pharmacy purposes.


Ryan Haumschild, PharmD, MS, MBA, CPEL

Latest:

Potential for Precision: Exploring Targeted Therapies in mCRC Care

Panelists discuss how the importance of having pharmacists embedded in oncology clinics has transformed metastatic colorectal cancer care by enabling real-time decision-making and dose adjustments, while highlighting that these are exciting times with multiple new oral treatment options that patients often prefer over infusions, though managing adherence and side effects remains challenging, and emphasizing that current targeted therapy opportunities include rare but actionable NTRK fusions, HER2 amplifications (3% of cases with multiple treatment options), and KRAS G12C mutations (3% of cases), with future promise in pan-RAS inhibitors, expanded immunotherapy beyond MSI-high tumors, and combination therapies, though dermatologic toxicity from targeted agents like RAS inhibitors will likely be the rate-limiting factor requiring better assessment tools and multidisciplinary management including dermatology support.



Arun Jesudian, MD

Latest:

Hepatic Encephalopathy: Critical Insights and Closing Thoughts

In their concluding remarks, Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, summarize the key takeaways and highlight the persistent unmet needs in the management of hepatic encephalopathy.


Sharon Xu, PharmD, BCOP

Latest:

A Step Forward: Optimizing the Delivery of Pegaspargase Therapy in Adult Patients With ALL

Delayed pegaspargase reduces hepatotoxicity without affecting outcomes.


Dimitrios Papadopoulos, RPHT, CPHT, IN-D

Latest:

10 Tips to Survive a Toxic Work Environment

Maintaining a strict work-life balance, setting boundaries, and trusting instincts can help technicians manage a challenging workplace.


Megan Schwartz, BS, PharmD Candidate 2024

Latest:

FDA, USP Advance Standardization, Regulation of Cannabis Nationally

Quality standards and national regulation help to establish its role as medicine.


Amy Duong, PharmD, BCACP

Latest:

Expert: Overcoming Challenges in CIDP Pharmacotherapy Management

Amy Duong, PharmD, BCACP, highlights the importance of patient counseling and addressing logistical challenges in treating patients with chronic inflammatory demyelinating neuropathy (CIDP).


Jordan D. Scott, PharmD

Latest:

Lisocabtagene Maraleucel Expands the Therapeutic Landscape for Relapsed/Refractory Non-Hodgkin Lymphoma

This CAR T-cell therapy has revolutionized the management of high-risk and relapsed or refractory disease.

© 2025 MJH Life Sciences

All rights reserved.